Silver Spring, MD, July 20, 2018 (GLOBE NEWSWIRE) -- The Association of Public Health Laboratories (APHL) has been awarded a five-year cooperative agreement of up to $7.5 million by the Genetic Services Branch of the US Health and Human Services Health Resources and Services Administration (HRSA) to maintain and manage the Newborn Screening Technical assistance and Evaluation Program (NewSTEPs). A component of the APHL Newborn Screening and Genetics Program, NewSTEPs provides quality improvement initiatives to strengthen newborn screening systems, a data repository, technical assistance and resources to state newborn screening programs and stakeholders.

"We are honored to receive this award,” said Jelili Ojodu, director of APHL’s Newborn Screening and Genetics Program and director of NewSTEPs. “This funding will allow us to continue provide states with robust and comprehensive tools that will allow them to improve the efficiency of the services they provide to newborn babies.”

Named one of the ten greatest public health achievements of the 20th century, newborn screening saves or improves the lives of more than 12,000 babies annually in the US. For babies who test positive for one of the genetic, metabolic, heart or hearing conditions, newborn screening can prevent serious health problems or even death.

NewSTEPs helps facilitate newborn screening initiatives and improve programmatic outcomes to enhance the quality of the newborn screening system through data driven quality improvements.

###

This project is 100% supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $1,500,000. The contents are those of the author(s) and do not necessarily represent the official views of, nor endorsement, by HRSA, HHS or the U.S. Government.

The Association of Public Health Laboratories (APHL) works to strengthen laboratory systems serving the public's health in the US and globally. APHL's member laboratories protect the public's health by monitoring and detecting infectious and foodborne diseases, environmental contaminants, terrorist agents, genetic disorders in newborns and other diverse health threats.

Michelle Forman
240.485.2793
michelle.forman@aphl.org